BCLI(Delisted)
BrainStorm CellยทNASDAQ
--
--(--)
BCLI Profile
Brainstorm Cell Therapeutics Inc.
A leading developer of cellular therapies for neurodegenerative diseases
1325 Avenue of Americas, 28th Floor, New York, NY 10019
--
BrainStorm Cell Therapeutics Inc., was incorporated under the laws of Washington State on September 22, 2000 and re-incorporated in Delaware on November 15, 2006. The Company is a leading biotechnology company dedicated to the development and commercialization of best-in-class autologous cell therapies for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis; progressive multiple sclerosis (" PMS "); Alzheimer's disease (" AD "); and neurodegenerative diseases. The Company's proprietary cell therapy platform, NurOwn, utilizes cell culture methods to induce autologous bone marrow mesenchymal stem cells (" MSCs ") to secrete high levels of neurotrophic factors (" NTFs "), modulate neuroinflammatory and neurodegenerative disease processes, promote neuron survival and improve neurological function.
